A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/1999
10/14/1999	WO1999051232A1 Antagonists of gonadotropin releasing hormone
10/14/1999	WO1999051231A1 Antagonists of gonadotropin releasing hormone
10/14/1999	WO1999051214A2 Progestogen-only contraceptive kit
10/14/1999	WO1999051185A2 Human galactosyl transferases
10/14/1999	WO1999042089A3 Use of thiadiazolo[4,3-a]pyridine derivatives
10/14/1999	WO1999039702A3 Method for regulating size and growth of vascularized normal tissue
10/14/1999	CA2326606A1 Aminoalkyl substituted 9h-pyridino¬2,3-b\|indole and 9h-pyrimidino¬4,5-b\|indole derivatives:crf1 and npy1 receptors
10/14/1999	CA2326383A1 Aminoalkyl substituted pyrrolo¬2,3-b\|pyridine and pyrrolo¬2,3-d\|pyrimidine derivatives: modulators of crf1 receptors
10/14/1999	CA2326319A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino¬2,3-b\|indole and 5,6,7,8-tetrahydro-9h-pyrimidino¬4,5-b\|indole derivatives: crf1 specific ligands
10/14/1999	CA2326185A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2326184A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2326143A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2326140A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2326139A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2325995A1 Antagonists of gonadotropin releasing hormone
10/14/1999	CA2325007A1 Human galactosyl transferases
10/14/1999	CA2324984A1 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0948524A1 Peptides agonists of bradykinine b 2? receptor
10/13/1999	EP0948352A1 Chlamydia vaccines
10/13/1999	EP0948343A1 Alkyl peptide amides and applications
10/13/1999	EP0775339B1 Current-to-pressure transducer with selectable, adjustable input filter
10/13/1999	CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999	CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999	CN1231196A Capsule for promoting male sexual function and preparation process
10/13/1999	CN1231194A Capsule for treating pointed condyloma and preparation process
10/13/1999	CN1231193A Capsule for treating gonorrhea and preparation method
10/13/1999	CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999	CN1045597C Alkylenediamine derivatives having heterocyclic group and medicinal composition thereof
10/13/1999	CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/12/1999	US5965763 Biphenyl compounds
10/12/1999	US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999	US5965732 Sulfonamide endothelin antagonists
10/12/1999	US5965693 Isolated polynucleotides; diagnosis and treatment of autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disorder, viricides, bactericides, fungicides and anticarcinogenic agents
10/12/1999	US5965610 Mixture containing chlorhexidine gluconate and zinc gluconate
10/12/1999	US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999	US5965529 Inhibiting nitric oxide dependent contractility of the uterus
10/12/1999	US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/07/1999	WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999	WO1999050396A1 Nek1-related protein kinase
10/07/1999	WO1999050276A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999	WO1999050275A2 Macrolide lhrh antagonists
10/07/1999	WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999	WO1999037309A9 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperinsulinemia, hyperandrogenism, hyperlipidemia and/or anovulation
10/07/1999	WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999	CA2325521A1 Macrolide lhrh antagonists
10/07/1999	CA2325519A1 3',3'-n-bis-substituted macrolide lhrh antagonists
10/07/1999	CA2324652A1 Nek1-related protein kinase
10/07/1999	CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/06/1999	EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999	EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999	EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999	EP0946196A1 Method for treating symptoms of diabetes
10/06/1999	CN1230888A Oral contraceptive
10/06/1999	CN1230434A Recipe of syphilis treating medicine
10/05/1999	US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999	US5962497 A 3,4-diphenyl substituted chroman compound
10/05/1999	US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999	US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999	US5962444 Hormone inhibitor; hormone replacement therapy
10/05/1999	US5962049 Boron carbohydrate complexes and uses thereof
10/05/1999	US5962021 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
10/05/1999	US5961980 Bowman-birk inhibitor compositions and methods for the treatment of genitourinary diseases
10/05/1999	CA2195924C 3-aza and 3-oxa-piperidone tachykinin antagonists
09/1999
09/30/1999	WO1999049038A2 Human calcium-binding proteins
09/30/1999	WO1999049037A2 Protein phosphatase-related molecules
09/30/1999	WO1999048902A1 Azt derivatives exhibiting spermicidal and anti-viral activity
09/30/1999	WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999	WO1999048496A1 Therapy of estrogen-associated disorders
09/30/1999	WO1999048477A1 Topical hormonal composition with systemic effect
09/30/1999	WO1999041387A3 Prostate-associated serine protease
09/30/1999	WO1999038506A3 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
09/30/1999	WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999	CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase
09/30/1999	CA2325631A1 Therapy of estrogen-associated disorders
09/30/1999	CA2325460A1 Azt derivatives exhibiting spermicidal and anti-viral activity
09/30/1999	CA2323640A1 Human calcium-binding proteins
09/30/1999	CA2323605A1 Protein phosphatase-related molecules
09/29/1999	EP0944631A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/29/1999	EP0944613A1 Novel benzopyran derivatives
09/29/1999	EP0474645B1 Protein complex
09/29/1999	CN1230184A Arylamino fused pyridines and pyrimidines
09/29/1999	CN1229671A Medicament 'Yujingling' for treating sexual disorder and its prepn. method
09/28/1999	US5959075 Testis-specific insulin homolog polypeptides
09/28/1999	US5958953 Substituted indazole derivatives
09/28/1999	US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists
09/28/1999	US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
09/28/1999	US5958916 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
09/28/1999	US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
09/28/1999	US5958878 For treating male and non-pregnant female mammals
09/28/1999	US5958709 Processes for identifying compounds that bind to the human Y4 receptor
09/28/1999	US5958427 Locally dilating blood vessels in a mammal by administering a nonpolymeric mucosally impermeant nitric oxide donor compound selected from the group of a tertiary amino or quaternary amino nitric oxide donor; male impotence, aphrodisiac
09/28/1999	US5958399 Vaginally administering composition comprising condensation polymer of aromatic sulfonic acid and aldehyde in physiologically acceptable carrier, prior to or after sexual intercourse
09/26/1999	CA2264260A1 Polynucleotide molecules encoding neospora proteins
09/23/1999	WO1999047642A2 Development of normal offspring from oocytes injected with freeze-dried spermatozoa
09/23/1999	WO1999047521A1 HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
09/23/1999	WO1999047154A1 Dipeptide caspase inhibitors and the use thereof
09/23/1999	WO1999047149A1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
09/23/1999	WO1999041374A3 Human short-chain tnf-receptor family protein
09/23/1999	WO1999012531A3 Hormonal contraceptive

1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 557